Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced
2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy
2023-08-25 08:15
Antheia Achieves Major Commercial Milestone
2023-08-25 08:01
Laekna, Inc. (2105.HK) Announces Interim Results 2023
2023-08-25 08:00
YS Biopharma Announces Purchase of Shares by Company Officers
2023-08-25 04:15
Ping An Health announces 2023 interim results
2023-08-24 20:58
Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA
2023-08-24 20:00
Vittra APS Unique composite by FGM is appointed as a solution to a clinical problem by the renowned agency Dental Advisor
2023-08-24 18:00
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
2023-08-24 14:00
MRI Software's first 'Voice of the Strata Manager' report reveals unseen pressures of high-demand real estate industry job
2023-08-24 13:02
PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor
2023-08-24 09:51
Everest Medicines Announces Interim Results for First Half of 2023
2023-08-24 08:15
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs
2023-08-24 07:59
Salvia BioElectronics: First-Ever Patient Treated with Breakthrough Neuromodulation Solution for Severe Migraine and Cluster Headache in Australia
2023-08-24 05:45
Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023
2023-08-24 04:15
Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position
2023-08-23 22:00
Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit
2023-08-23 20:06
Innovent Announces 2023 Interim Results and Business Updates
2023-08-23 19:38
Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations
2023-08-23 19:21
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US
2023-08-23 18:07
1
88
89
90
91
92
896